HIGHLIGHTS
- who: Yulia Davydova and collaborators from the National Medical Research Center for Hematology, Moscow, Russia have published the research: Immunophenotype of Measurable Residual Blast Cells as an Additional Prognostic Factor in Adults with B-Cell Acute Lymphoblastic Leukemia, in the Journal: Diagnostics 2023, 21 of /2023/
- what: The aim of this study is to assess an immunophenotype significance of MRD in B-ALL patients enrolled in a Russian multicenter study.
SUMMARY
For adult patients (n=2076), the 10 year EFS was 64% in MRD-negative cases vs. 21% for MRD-positive . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.